March 29, 2016

Sponsored by

Webinar Description:

Novel Lipid Supplement, Cell Ess, Increases Antibody Production in CHO Cells for Industrial Manufacturing Applications. Enhancing protein production is a common bioproduction goal. Cell Ess, when used to supplement to an optimized cell and media system, resulted in a 37% increase in productivity per cell. Used as a 5% feed, it resulted in a 25% increase in yield and extension of peak protein production. Our results suggest that an increase in protein production may not require a change in the metabolic state of the cells.

Learning Objectives:

• How a novel media supplement for large scale bioproduction was used to significantly boost mAb protein yield as a continuous feed in a previously optimized system.
• That the supplement works in a scalable fashion from shaker flask to wave bag bioreactor
• How one can increase protein yield without increasing biomass, i.e. fewer cells become more efficient producing the engineered protein of interest.

Who Should Attend:

• Those in early development of bioproduction of proteins in eukaryotic cells
• Those in media optimization or yield optimization for scaled bioproduction of proteins
• Department Directors, Program Directors, Project leaders, involved in optimization of large scale bioproduction of proteins.

Speaker:

Dr. Adam Elhofy, Ph.D.

CSO

Essential Pharmaceuticals

Dr Elhofy developed the core technology for the Ess line of products and aided in creating patents around novel uses of materials. Dr. Elhofy has over 14 years of scientific research experience in the areas of immunology, neuroscience, and oncology. He was funded by both the National Institutes of Health and the Multiple Sclerosis society as an investigator at Northwestern University Medical School. His doctoral research won him the award of the Top 5 trainee scientists by the American Association of Immunologists. Dr. Elhofy has 14 scientific publications in peer reviewed journals. He has played a variety of roles with start-up biotech companies ranging from Principal Investigator to Director of Corporate Development.